This article discusses DaVita's stock performance, noting a 21.4% gain over three months. It asks how investors should assess and potentially "play" t...
Neutral
This article provides financial information for DaVita Inc. (TRL) specifically focusing on its EBITDA per share. It appears to be a stub or partial fi...
Bearish
DaVita Inc. (DVA) shares recently gained 3.8%, but the stock is considered "Modestly Overvalued" by GuruFocus with a GF Value of $172.69 against a cur...
Bullish
The article highlights two DaVita teammates, Chris Harris and Angela Laino, who have experienced the "gift of life" from different perspectives within...
Bullish
DaVita (DVA) reported strong Q1 2026 diluted EPS of $2.87, representing a 43.5% year-over-year increase, with revenues reaching $3.42 billion, leading...
Bearish
DaVita (US23918K1088) has seen a strong rally over the past year, but its stock is now facing increased volatility due to fresh regulatory headlines a...
Bullish
Health systems like Centerwell, Rush, and DaVita are investing in chronic disease technology, showing promise for AI in this sector. This comes as Nou...
Bullish
DaVita Inc. (DVA) recently reported strong Q1 2026 results, with increased revenue and net income, alongside significant share repurchases totaling bi...